baber/WOPTO huggingface dataset:
Patent AU-5709801-A (AU)
Title: Low extracorporeal volume treatment system
Inventor: BRIGGS DENNIS
IPC: A61M1/02
Filed: 2001-04-19
Abstract: A means, apparatus, and system for reducing the net fluid volume deficiency in a patient during a medical treatment process. The invention seeks to modify a batch-type process to achieve the efficiency of a continuous process by precisely measuring the net change in fluid volume within a patient and dispensing the appropriate amount of biological fluids to a patient via IV lines or by recycling blood components into the patient while biological fluids are being withdrawn. The apparatus includes subcomponent lines, valving means, pumping means, load cells, storage chambers, a centrifuge, and centrifuge bowls. The system may have numerous feedback components to accurately measure and control the flow rates and amount of fluid dispensed to a patient.
Patent AU-5738686-A (AU)
Title: Cathode-ray tube arc-over protection for digital data in television display apparatus
Inventor: STOUGHTON JOHN WILLIAM
IPC: G06F11/00
Filed: 1986-05-13
Abstract: Arc-over in the cathode ray tube (21) of a digital television receiver produces a large current pulse which, when it discharges via the chassis ground, disrupts the reference ground potentials of other circuitry coupled to the chassis ground. The affected circuitry includes digital data storage elements which may experience random state changes caused by the fluctuating ground potential. The CRT arc-over condition is detected by circuitry (460-466) which applies a pulse to the reset terminal of a microprocessor (440), causing it to restore the potentially corrupted data in the data storage elements using preset data stored in a less volatile programmable read only memory (452).
Patent AU-5857899-A (AU)
Title: Use of tgf-beta inhibitors for treating cerebral disorders
Inventor: KRIEGELSTEIN KERSTIN
IPC: A61K38/00
Filed: 1999-09-01
Abstract: The present invention relates to the use of a compound capable of substantially inhibiting the biological activity of TGF- beta  on predamaged neurons, for treating cerebral disorders, and to pharmaceutical compositions containing said compound and a second compound for disintegrating blood clots.
Patent AU-5946096-A (AU)
Title: Method and kit for imaging and treating organs and tissues
Inventor: GOLDENBERG MILTON DAVID
IPC: A61K47/48
Filed: 1996-07-12
Abstract: A therapeutic application for organ- and tissue-targeting antibodies conjugated with a toxic agent is for the ablation of certain normal cells and tissues as part of another therapeutic strategy, such as in bone marrow ablation with antibodies against bone marrow cells of particular stages of development and differentiation, and in the cytotoxic ablation of the spleen in patients with lymphoma or certain immune diseases, such as immune thrombocytopenic purpura.
Patent AU-6150390-A (AU)
Title: Toroidal hyper-expansion rotary engine, compressor, expander, pump and method
Inventor: CHOMYSZAK STEPHEN M
IPC: F02B75/12
Filed: 1990-08-09
Abstract: An engine (10) has a pair of intermeshing rotors (12) and (14). The rotor (12) has intake/compression vanes (18), and the rotor (14) has expansion/exhaust vanes (22). In operation of the engine (10), the intake/compression vanes (18) of rotor (12) interact with the expansion/exhaust vanes (22) of rotor (14) to produce intake/compression chambers and expansion/exhaust chambers. The intake/compression chambers are separate from the expansion/exhaust chambers, and the expansion/exhaust chambers each have a greater volume than each of the intake/compression chambers.
Patent AU-6213496-A (AU)
Title: PVC-free multilayer tube for medical purposes, process for the production thereof and use
Inventor: HEILMANN KLAUS
IPC: B29C48/12
Filed: 1996-08-16
Abstract: According to the invention, strong adhesion of the layers to each other and simple formation of a strong and leakproof connection with bags or connectors made from polypropylene or polycarbonate during steam sterilisation is achieved by the first plastic material containing at least one polymer which is dimensionally stable at temperatures of >/=121 DEG  C., while the second plastic material contains at least one polymer which is no longer dimensionally stable at temperatures of >/=121 DEG  C. A layer C) (2) is optionally present, the plastic material of which contains at least one polymer which is dimensionally stable at temperatures of >/=121 DEG  C. The invention can be used for medical purposes, in particular as a fluid line in dialysis, infusion or artificial feeding, primarily in connection with connectors or medical bags.
Patent AU-6384001-A (AU)
Title: Pourable frying composition
Inventor: BAUER-PLANK CHRISTINA
IPC: A23D7/02
Filed: 2001-04-06
Abstract: Pourable frying products that comprise an ester of citric acid with a mono- or diglyceride show improved spattering behaviour.
Patent AU-6572100-A (AU)
Title: New effectors of dipeptidyl peptidase iv for topical use
Inventor: DEMUTH HANS-ULRICH
IPC: A61P1/02
Filed: 2000-08-20
Abstract: Amino acid cyclic amide derivatives (I) are new. Amino acid cyclic amide derivatives of formula (I) are new. B-A-C (I) A : an alpha -amino acid with a side-chain functional group; B : a molecule covalently bonded to the side-chain functional group of A, selected from oligopeptides with a chain length of up to 20 amino acids, polyethylene glycol (PEG) with a molecular weight of up to 20,000, optionally substituted organic amines, amides, alcohols, acids or aromatics with 8-50 C atoms; C : a thiazolidine (Thia), pyrrolidine, hydroxyproline, dehydroproline or piperidine group forming an amide bond with A. ACTIVITY : Antiinflammatory; antiallergic; dermatological; antiarthritic; antipsoriatic; immunomodulator; cytostatic. MECHANISM OF ACTION : Dipeptidyl peptidase IV (DP IV) modulator. The serum DP IV activity of rats after oral administration of 5 mu M Glu(PEG)-Thia was increased by almost 10% after 20 minutes and then decreased to 90% of the initial level over the next 100 minutes.
Patent AU-6781894-A (AU)
Title: Orthopedic casting tape
Inventor: GREEN RICHARD
IPC: A61L15/07
Filed: 1994-05-04
Abstract: The invention is directed to orthopedic casting tapes including the combination of a knit tape and a hardenable liquid resin coated onto the knit tape. The knit tape includes alternating thick and thin portions extending transversely across the tape. Such casting tapes have been found to be capable of improving cast strength.
Patent AU-6870901-A (AU)
Title: Respiratory syncytial virus vaccines expressing protective antigens from promotor-proximal genes
Inventor: KREMPL CHRISTINE D
IPC: A61P31/14
Filed: 2001-06-22
Abstract: Recombinant respiratory syncytial virus (RSV) having the position of genes shifted within the genome or antigenome of the recombinant virus are infectious and attenuated in humans and other mammals. Gene shifted RSV are constructed by insertion, deletion or rearrangement of genes or genome segments within the recombinant genome or antigenome and are useful in vaccine formulations for eliciting an anti-RSV immune response. Also provided are isolated polynucleotide molecules and vectors incorporating a recombinant RSV genome or antigenome wherein a gene or gene segment is shifted to a more promoter-proximal or promoter-distal position within the genome or antigenome compared to a wild type position of the gene in the RSV gene map. Shifting the position of genes in this manner provides for a selected increase or decrease in expression of the gene, depending on the nature and degree of the positional shift. In one embodiment, RSV glycoproteins are upregulated by shifting one or more glycoprotein-encoding genes to a more promoter-proximal position. Genes of interest for manipulation to create gene position-shifted RSV include any of the NS1, NS2, N, P, M, SH, M2(ORF1), M2(ORF2), L, F or G genes or a genome segment that may be part of a gene or extragenic. A variety of additional mutations and nucleotide modifications are provided within the gene position-shifted RSV of the invention to yield desired phenotypic and structural effects.
Patent AU-7037596-A (AU)
Title: Chirped-pulse multiple wavelength telecommunications system
Inventor: KNOX WAYNE HARVEY
IPC: H04B10/2581
Filed: 1996-10-24
Abstract: An apparatus and method provides optical multiple wavelength signals using a single optical broadband source to generate many independent optical wavelength channels. An optical transmitter includes a pulse chirping device which separates the frequency components of periodic optical pulses in the time domain forming separate wavelength channels which are separately modulated by a high-speed broadband optical modulator. A receiver includes a passive splitter to separate the individual wavelength channels. The chirped-pulse transmitter can then be conveniently adjusted to provide optimum overlap of wavelength channels with the modulating channel spectra. <IMAGE>
Patent AU-7546896-A (AU)
Title: Polypeptides derived from the human immunodefficiency virus endonuclease protein, and related kits and assays
Inventor: CHIODI FRANCESCA
IPC: C07K7/08
Filed: 1996-12-19
Abstract: A polypeptide linked to a solid matrix useful as a solid support of a diagnostic kit is disclosed. The polypeptide has the formula: X-Glu-Thr-Gly-Gln-Glu-Thr-Ala-Tyr-Phe-B-Leu-Lys-Leu-Ala-Gly-Arg-Trp-Pro-Val-Lys-Z, wherein B is Ile or Leu, X is a chain of from 1 to 20 amino acid residues or an amino-terminal group and Z is a chain of from 1 to 20 amino acid residues or a carboxy-terminal group. The polypeptide immunologically mimics HIV endonuclease.
Patent AU-7621600-A (AU)
Title: Human rnase h and oligonucleotide compositions thereof
Inventor: CROOKE STANLEY T
IPC: C12N9/22
Filed: 2000-09-29
Abstract: The present invention provides oligonucleotides that can serve as substrates for human Type 2 RNase H. The present invention is also directed to methods of using these oligonucleotides in enhancing antisense oligonucleotide therapies.
Patent AU-7668494-A (AU)
Title: Absorption body
Inventor: LINDQUIST BENGT
IPC: D06C23/04
Filed: 1994-09-08
Abstract: An absorption body (10) is disclosed which is suitable for use in e.g. sanitary napkins. The body includes at least one layer of an absorbent material and has a plurality of longitudinally extending embossed channels (12). In order to promote distribution of discharged body fluid across the absorption body, at least three channels are present, and the layer of absorbent material provides the absorption body (10) with a basis weight of between about 80 and 240 g/m<2>, preferably between about 120 and 160 g/m<2>. The body is produced from a continuous web of material which is embossed by passing the web between a pair of heated rollers. The absorption body may be a laminate of two or more layers of absorbent material and super-absorbent material may be present. <IMAGE>
Patent AU-7720391-A (AU)
Title: C63-amide derivatives of 34-de(acetylglucosaminyl)-34-deoxy- teicoplanin and their use as medicaments against bacteria resistant to glycopeptide antibiotics
Inventor: MALABARBA ADRIANO
IPC: A61P31/04
Filed: 1991-05-20
Abstract: C<6><3>-Amide derivatives of 34-de(acetylglucosaminyl) -34-deoxy-teicoplanin wherein the amide moiety is derived from a di- or poly-amine. The derivatives are prepared by reacting 34-de(acetylglucosaminyl)- 34-deoxy-teicoplanins with an active esters forming reagent such as chloroacetonitrile and then contacting said active esters with the appropriate di- or polyamine. The amide derivatives which are active against Gram-positive microorganisms, in particular against Group A Streptococci were found to be active also against bacteria which are resistant to glycopeptide antibiotics.
Patent AU-7730191-A (AU)
Title: Use of magnesium-pyridoxal-5'-phosphate-glutaminate for the prevention of diseases which result from vascular lesions
Inventor: SCHNEIDER WERNER DR RER NAT
IPC: A61K33/32
Filed: 1991-05-24
Abstract: The invention relates to the use of magnesium-pyridoxal-5'-phosphate-glutaminate to prepare a pharmaceutical suitable for the reduction of LDL-bound peroxides and for the prophylaxis of vascular lesions resulting therefrom in the absence of hypercholesteraemia or hyperlipidaemia.
Patent AU-7757700-A (AU)
Title: Shade operator with release brake
Inventor: JUDKINS REN
IPC: E06B9/78
Filed: 2000-08-08
Abstract: An operator for a window covering held on a roller or axle has a stationary member having a central cavity and a first bore sized and positioned so that the roller can pass through the bore into the central cavity. A release brake is positioned so that the axle or roller can pass through and be held by the release brake. An inertial ring within the central cavity of the stationary member, surrounds a coil spring which encircles the axle. A release member is provided adjacent the release brake and the inertial ring. The release member is sized and positioned so that when the release ring is in a first position the release member will not engage the inertial ring or the release brake and when the release member is moved in a selected direction the release member will engage and turn the release brake and the inertial ring. A spool is positioned within the central cavity of the stationary member adjacent the inertial ring. A rewind spring is connected between the spool and the stationary member such that when a force acts on the spool to turn the spool in the first direction from the initial position the rewind spring will tighten and when the force is removed the spring will loosen causing the spool to return to the initial position.
Patent AU-7763487-A (AU)
Title: Method and apparatus for the detection of the fluid level in a tank being filled
Inventor: VOGEL JOHANNES ALBERTUS
IPC: B67D7/46
Filed: 1987-08-27
Abstract: Acoustic signals are transmitted through the fluid flow of a fuel delivery pump to a tank to be filled. From reflection signals the fluid level in the tank is detected and a timely disconnection of the pump can be effected in order to prevent fuel losses.
Patent AU-7779994-A (AU)
Title: Stabilized oligonucleotides and their use
Inventor: PEYMAN ANUSCHIRWAN
IPC: C07H21/00
Filed: 1994-11-11
Abstract: Oligonucleotides (I) having at least one non-terminal pyrimidine nucleoside modified and additionally having the 5'- and/or 3'-terminal modified are new, with some specific exclusions. Oligonucleotides (I) having at least one non-terminal pyrimidine nucleoside modified and additionally having the 5'- and/or 3'-terminal modified are new, with the exception of oligonucleotides in which all of the nucleosides are modified and Cys asterisk -Ala-Cys-Cys-Ala asterisk -Ala-Cys-Cys-Thr asterisk -Cys-Thr-Thr-Cys asterisk -Cys-Ala-Cys-Ala-, Cys asterisk -Ala-Cys asterisk -Cys-Ala asterisk -Ala-Cys asterisk -Thr-Thr-Cys-Thr asterisk -Thr-Cys asterisk -Cys-Ala asterisk -Cys-Ala-, Cys-Ala asterisk -Cys-Cys asterisk -Ala-Ala asterisk -Cys-Thr asterisk -Thr-Cys asterisk -Thr-Thr asterisk -Cys-Cys asterisk -Ala-Cys asterisk -Ala- and Cys-Ala-Cys asterisk -Cys asterisk -Ala-Ala-Cys asterisk -Thr asterisk -Thr-Cys-Thr asterisk -Thr asterisk -Thr-Cys-Cys-Ala asterisk -Cys asterisk -Ala. An Independent claim is included for the preparation of (I) by chemical synthesis.
Patent AU-7961791-A (AU)
Title: Novel composite and emulsion composition
Inventor: NAKAMA YASUNARI
IPC: C09K23/22
Filed: 1991-06-15
Abstract: A novel composite comprising an ampholytic surfactant and/or a semipolar surfactant, a higher fatty acid and, if necessary, a clay mineral; and an emulsion composition containing the same. <IMAGE>
Patent AU-7976700-A (AU)
Title: Steel material, its use and its manufacture
Inventor: SANDBERG ODD
IPC: C21D9/38
Filed: 2000-09-27
Abstract: The invention concerns a steel material which consists of a steel having the following chemical composition in weigh-%: 1.0-1.9 C, 0.5-2.0 Si, 0.1-1.5 Mn, 4.0-5.5 Cr, 2.5-4.0 (Mo+W/2), however max 1.0 W, 2.0-4.5 (V+Nb/2), however max 1.0. Nb, balance iron and impurities in normal amounts in the form of residual elements from the manufacturing of the steel, and with a microstructure, which in the hardened and tempered condition of the steel contains 5-12 vol-% MC-carbides, at least about 80 vol-% of the carbides having a size which is larger than 3 mum but smaller than 25 mum preferably smaller than 20 mum, and, prior to tempering, 0.50-0.70 weight-% carbon, which is dissolved in the martensite in the hardened condition of the steel. The material is intended for cold work tools, in the first place for homogenous rolls for cold rolling of meta, strips.
Patent AU-8008898-A (AU)
Title: Method and device for detecting catheter-tissue contact and interaction with tissue during catheter ablation
Inventor: MUNTERMANN AXEL
IPC: A61B18/12
Filed: 1998-04-01
Abstract: In a process and an apparatus for the detection of the contact and/or the interaction of a catheter arranged in a patient's vessel, in particular in a patient's blood stream, with the patient's tissue, in order to contribute to an improved detection of this contact or to make it possible for the first time to permit statements during an ablation process regarding the ablation depth or regarding the interaction with the tissue, a device is provided for the detection of a voltage at at least one catheter electrode, wherein the voltage between the catheter electrode and a further electrode is measured, and wherein the further electrode is a neutral electrode in contact with the patient's body or a further electrode installed on the catheter.
Patent AU-8032682-A (AU)
Title: Formulations of known antimycotic azoles
Inventor: BITTERA MIKLOS VON
IPC: A61K31/415
Filed: 1982-02-10
Abstract: The invention relates to stick formulations of antimycotic azole derivatives containing, in addition to the antimycotic azole derivatives, 3 to 5% by weight relative to the formulation, of benzyl alcohol, 2.5 to 10% by weight, relative to the formulation of spreading agent and one or more auxiliaries.
Patent AU-8074387-A (AU)
Title: Polysubstituted diethylenetriamine pentacetic acid (DTPA) chelating agents
Inventor: GANSOW OTTO A
IPC: C07C211/15
Filed: 1987-09-04
Abstract: New polysubstituted diethylenetriaminepentaacetic acid chelates and protein conjugates of the same are described together with the methods of preparing such compounds. A method of delivering radiolabelled compound of the present invention to a target site while minimizing the distribution of the compound to non-targeted organs or tissues is also disclosed.
Patent AU-8202791-A (AU)
Title: Interactive communication and transport system for still pictures
Inventor: HANNINA RITA
IPC: H04L12/28
Filed: 1991-06-21
Abstract: PCT No. PCT/NL91/00104 Sec. 371 Date Dec. 18, 1992 Sec. 102(e) Date Dec. 18, 1992 PCT Filed Jun. 21, 1991 PCT Pub. No. WO91/20144 PCT Pub. Date Dec. 26, 1991.An interactive communication and transport system in which communication for the purpose of requests takes place between requesting receiving stations (B) and one or more request-processing transmitting stations (A) provided with a source (1-4) of information of separately specifiable bulk data (including picture data) via a relatively low-speed communication path in a first network (6), and the forwarding of the requested bulk data to receiving stations (B) specified in the requests by transmitting devices (14-17) takes place in a packet-switched mode via a relatively high-speed transmission path in a second network (10). Temporary destination addresses are assigned to the receiving stations (B) for the forwarding, and permission is granted for forwarding to the transmitting workstations (A) on request. The actual forwarding of data takes place after a respective transmitting station (A), which has received permission, has detected, by an "end of packet" detector (18), that transmission of a previous packet has been completed. The data channel along which picture data is transported is thus used more efficiently, and forwarding of picture data to a group of destinations is possible both on request and dynamically from the system.
Patent AU-8436691-A (AU)
Title: Pharmaceutical composition of florfenicol
Inventor: APELIAN HENRY M
IPC: A61P31/04
Filed: 1991-08-27
Abstract: An injectable pharmaceutical composition for veterinary use is disclosed comprising Florfenicol, N-methyl-2-pyrrolidone, polyethylene glycol and a viscosity reducing agent. The composition is chemically and physically stable, exhibits constant blood levels and does not product undesirable side effects.
Patent AU-8646291-A (AU)
Title: Mixed lipid-bicarbonate colloidal particles for delivering drugs or calories
Inventor: YESAIR DAVID W
IPC: A61K9/107
Filed: 1991-08-12
Abstract: A composition is disclosed containing non-esterified fatty acids having 14-18 carbon atoms, monoglycerides which are monoesters of glycerol and fatty acids having 14-18 carbon atoms, lysophosphatidylcholine in which the fatty acid moiety has 14-18 carbon atoms and bicarbonate. The compositions can optionally also contain bile salts. These compositions form submicron size colloidal particles and can act as vehicles for transporting orally administered drugs, sources of calories in the form of readily absorbable fats and as particles for topical application to the skin. A method of making these particles is also described.
Patent AU-9083291-A (AU)
Title: Foldable games booard for multiple games
Inventor: GARCIA JOSE LUIS AYALA
IPC: A63F3/02
Filed: 1991-12-04
Abstract: On the basis of the improvements of the invention, it is possible to obtain, after transformation of a single body, different boards for playing multiple games, starting from a rectangular sheet (L) divided in a predetermined number of equilateral triangles (1-17), which are equal to each other, each of them being provided with a pattern or a drawing which, in combination in a determined position, will form a different game board for each transformed figure, this being achieved by appropriately folding said sheet (L), along the joints which form the contiguous edges of the triangles, so as to obtain a planar body with hexagonal contour formed by six equal triangles susceptible of being transformed into another equal hexagon but showing as many distinct triangles, up to a total of five transformations, thereby obtaining as many game boards on the basis of the patterns or indicia which combine themselves appropriately in each planar hexagonal figure determined in each transformation. <IMAGE>
Patent AU-9656701-A (AU)
Title: Determination of ocular refraction from wavefront aberration data
Inventor: WILLIAMS DAVID
IPC: A61B3/028
Filed: 2001-10-04
Abstract: Ocular refraction is determined from wavefront aberration data, and an optimum customized correction is designed. The eye's wave aberration is measured by using a detector such as a Shack-Hartmann detector. From the aberration, an image metric is calculated, and the second-order aberrations which optimize that metric are determined. From that optimization, the refractive correction required for the eye is determined. The image metric is one of several metrics indicating the quality of the image on the retinal plane or a proxy for such a metric. The required refractive correction can be used to form a lens or to control eye surgery. If it is possible to detect more aberrations than can be corrected, those aberrations are corrected which most affect vision, or for which the eye's error tolerance is lowest.